HTTIPKV
HTTIPKV is a CAF-selective peptide. HTTIPKV specifically binds to recombinant TAS2R9. HTTIPKV selectively localizes to cancer-associated fibroblasts and the stroma of pancreatic ductal adenocarcinoma. Conjugation of HTTIPKV to liposomes enhances tumor accumulation and improves delivery of encapsulated CXCR2 inhibitors, thereby reducing tumor growth. HTTIPKV can be used for research on pancreatic ductal adenocarcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C36H62N10O10
- Masse moléculaire:794.94
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
Masse moléculaire 794.94
-
Formule C36H62N10O10
-
SMILES
O=C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@@H](C)CC)C(N1[C@@H](CCC1)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CNC=N2)N
-
Sequence
His-Thr-Thr-Ile-Pro-Lys-Val
-
Sequence Shortening
HTTIPKV
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- HTTIPKV
- Biochemical Assay Reagents
- BXPC3/CAF pancreatic ductal adenocarcinoma xenograft
- CXCR2 inhibitor
- GPCR
- TAS2R9
- cancer-associated fibroblast-selective peptide ligand
- cancer-associated fibroblasts
- liposomes
- pancreatic ductal adenocarcinoma
- pancreatic ductal adenocarcinoma stroma
- tumor growth
- Inhibitor
- inhibitor
- inhibit